These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 12646035

  • 1. A comparison of physiochemical property profiles of development and marketed oral drugs.
    Wenlock MC, Austin RP, Barton P, Davis AM, Leeson PD.
    J Med Chem; 2003 Mar 27; 46(7):1250-6. PubMed ID: 12646035
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lipid-based formulations for oral administration of poorly water-soluble drugs.
    Mu H, Holm R, Müllertz A.
    Int J Pharm; 2013 Aug 30; 453(1):215-24. PubMed ID: 23578826
    [Abstract] [Full Text] [Related]

  • 7. Molecular inflation, attrition and the rule of five.
    Leeson PD.
    Adv Drug Deliv Rev; 2016 Jun 01; 101():22-33. PubMed ID: 26836397
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Absorption classification of oral drugs based on molecular surface properties.
    Bergström CA, Strafford M, Lazorova L, Avdeef A, Luthman K, Artursson P.
    J Med Chem; 2003 Feb 13; 46(4):558-70. PubMed ID: 12570377
    [Abstract] [Full Text] [Related]

  • 11. Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties?
    Giordanetto F, Kihlberg J.
    J Med Chem; 2014 Jan 23; 57(2):278-95. PubMed ID: 24044773
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Quality guidelines for oral drug candidates: dose, solubility and lipophilicity.
    Bayliss MK, Butler J, Feldman PL, Green DV, Leeson PD, Palovich MR, Taylor AJ.
    Drug Discov Today; 2016 Oct 23; 21(10):1719-1727. PubMed ID: 27423371
    [Abstract] [Full Text] [Related]

  • 14. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.
    Zuegg J, Cooper MA.
    Curr Top Med Chem; 2012 Oct 23; 12(14):1500-13. PubMed ID: 22827520
    [Abstract] [Full Text] [Related]

  • 15. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA.
    Chem Res Toxicol; 2011 Sep 19; 24(9):1420-56. PubMed ID: 21790149
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmaceutical profiling in drug discovery.
    Kerns EH, Di L.
    Drug Discov Today; 2003 Apr 01; 8(7):316-23. PubMed ID: 12654544
    [Abstract] [Full Text] [Related]

  • 18. The physicochemical challenges of designing multiple ligands.
    Morphy R, Rankovic Z.
    J Med Chem; 2006 Aug 10; 49(16):4961-70. PubMed ID: 16884308
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.